Skip to main content
. Author manuscript; available in PMC: 2023 Sep 1.
Published in final edited form as: Ann Allergy Asthma Immunol. 2022 May 18;129(3):327–334. doi: 10.1016/j.anai.2022.05.005

Table 1.

Characteristics of Study Participants Overall and by Asthma Subtypes (N = 27,437)

Characteristics All No asthma Past asthma Current asthma
P value
Childhood onset Adult onset

All participants, % 100 87.4 4.4 2.7 5.5
Median age (y) 55 55 54 52 57
Male sex, % 46.7 48.0 42.2 44.7 30.0 <.001
Race/ethnicity, % <.001
 Non-Hispanic White 73.6 73.5 74.0 73.3 75.9
 Non-Hispanic Black 10.2 10.0 11.4 14.5 10.7
 Mexican American 9.8 10.1 9.5 7.2 7.1
 Other 6.3 6.4 5.1 5.0 6.3
Median PIR 3.3 3.4 3.5 3.0 2.7 <.001
Uninsured 11.7 11.9 12.0 11.6 8.1 .011
 Smoking, % <.001
 Current 17.7 17.4 17.2 23.0 21.1
 Former 27.4 27.0 30.8 26.3 31.3
Obesity, % 38.2 36.8 40.8 46.0 53.4 <.001
Airflow obstruction 20.4 18.6 26.0 38.2 35.7 <.001
Blood total cholesterol .06
 Borderline high 32.8 17.2 18.9 13.4 20.4
 High 17.4 33.0 31.3 30.0 32.1
Serum LDL cholesterol .38
 Borderline high 23.8 23.9 26.0 23.0 22.1
 High 12.1 12.1 12.2 7.5 14.3
Blood triglycerides .01
 Borderline high 16.4 16.5 15.3 12.3 18.8
 High 23.3 23.0 22.6 26.9 26.3
Diabetes 16.3 15.8 17.4 17.9 22.7 <.001
Hypertension 48.6 47.7 49.3 51.9 60.6 <.001
CVD 12.8 11.9 12.5 18.4 25.0 <.001
CKD 13.0 12.9 11.0 11.9 16.0 .03
Arthritis <.001
 Rheumatoid arthritis 5.4 5.1 5.2 12.1 9.1
 Osteoarthritis 15.7 15.0 18.6 15.5 25.9
 Other/Unknown 14.1 13.4 14.9 17.0 22.7
Cancer 14.1 13.7 15.1 14.9 19.2 <.001
Anemia 10.2 9.7 10.8 12.4 15.8 <.001
Depression 7.7 6.8 8.8 15.4 17.1 <.001
COPD 1.7 1.6 2.9 2.6 1.5 .02

Abbreviations: CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; CVD, cardiovascular disease; LDL, low density lipoprotein; PIR, poverty income ratio.

NOTE. Bold indicates significant difference.